Johnson & Johnson (JNJ)

NYQ – Real Time Price. Currency in USD

227.61

+3.35 (1.49%)

Market open: May 13, 2026, 10:26 AM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

94.18B

88.82B

85.15B

80.06B

Cost of goods sold

-29.55B

-27.86B

-26.43B

-24.32B

Gross Profit

64.63B

60.96B

58.72B

55.74B

Operating expenses (excl. COGS)

-38.50B

-40.13B

-36.56B

-34.53B

Operating Income

26.12B

20.82B

22.16B

21.21B

Non-operating income, total

6.46B

-4.14B

-7.10B

-1.85B

Pretax income

32.58B

16.69B

15.06B

19.36B

Equity in earnings

Taxes

-5.78B

-2.62B

-1.74B

-2.99B

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

26.80B

14.07B

13.33B

16.37B

Johnson & Johnson (JNJ)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Johnson & Johnson (JNJ)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Johnson & Johnson (JNJ)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Johnson & Johnson (JNJ)

Income Statement (Annual)

Income Statement (Annual)